c-Jun promotes cellular survival by suppression of PTEN

No abstract is available for this paper.

• Publication year

  2007

• Venue

  Cell Death and Differentiation

• Publication date

  2007-02-01

• Fields of study

  Biology, Medicine

• Identifiers
  DOI 10.1038/sj.cdd.4401946PMID 16676006
• External record

  Open on Semantic Scholar

• Source metadata

  Semantic Scholar, PubMed

• No claims are published for this paper.

• No concepts are published for this paper.

• The PI 3-kinase/Akt signaling pathway is activated due to aberrant Pten expression and targets transcription factors NF-κB and c-Myc in pancreatic cancer cells

  2005cited by this paper
• Relief of p53-mediated Telomerase Suppression by p73*

  2005cited by this paper
• DJ-1, a novel regulator of the tumor suppressor PTEN.

  2005cited by this paper
• Distinct roles for JNK1 and JNK2 in regulating JNK activity and c-Jun-dependent cell proliferation.

  2004cited by this paper
• Targeting JNK3 for the treatment of neurodegenerative disorders.

  2004cited by this paper
• AP-1 blockade in breast cancer cells causes cell cycle arrest by suppressing G1 cyclin expression and reducing cyclin-dependent kinase activity

  2004cited by this paper
• Promoter methylation of the PTEN gene is a common molecular change in breast cancer

  2004cited by this paper
• The PI 3-kinase/Akt signaling pathway is activated due to aberrant Pten expression and targets transcription factors NF-κB and c-Myc in pancreatic cancer cells

  2004cited by this paper
• The AP-1 transcription factor c-Jun is required for efficient axonal regeneration.

  2004cited by this paper
• AP-1: a double-edged sword in tumorigenesis

  2003cited by this paper
• JNK-mediated BIM phosphorylation potentiates BAX-dependent apoptosis.

  2003cited by this paper
• Regulation of constitutive expression of mouse PTEN by the 5′-untranslated region

  2003cited by this paper
• Liver tumor development. c-Jun antagonizes the proapoptotic activity of p53.

  2003cited by this paper
• Activation of the JNK-AP-1 signal transduction pathway is associated with pathogenesis and progression of human osteosarcomas.

  2003cited by this paper
• Significance of TP53 mutations in human cancer: A critical analysis of mutations at CpG dinucleotides

  2003cited by this paper
• JNK1 modulates osteoclastogenesis through both c-Jun phosphorylation-dependent and -independent mechanisms

  2002cited by this paper
• AP-1 as a regulator of cell life and death

  2002cited by this paper
• Apoptosis induced by adenovirus-mediated p53 gene transfer in human glioma correlates with site-specific phosphorylation.

  2002cited by this paper
• Identification of genotoxic stress in human cells by fluorescent monitoring of p53 expression.

  2001cited by this paper
• Regulation of PTEN transcription by p53.

  2001cited by this paper
• β-Amyloid Induces Neuronal Apoptosis Via a Mechanism that Involves the c-Jun N-Terminal Kinase Pathway and the Induction of Fas Ligand

  2001cited by this paper
• The Egr-1 transcription factor directly activates PTEN during irradiation-induced signalling

  2001cited by this paper
• Jun N-terminal kinase 2 modulates thymocyte apoptosis and T cell activation through c-Jun and nuclear factor of activated T cell (NF-AT).

  2001cited by this paper
• Expression of Jun family members in human colorectal adenocarcinoma.

  2000cited by this paper
• c-Jun-Dependent CD95-L Expression Is a Rate-Limiting Step in the Induction of Apoptosis by Alkylating Agents

  2000cited by this paper
• A Novel AP-1 Element in the CD95 Ligand Promoter Is Required for Induction of Apoptosis in Hepatocellular Carcinoma Cells upon Treatment with Anticancer Drugs

  2000cited by this paper
• Control of cell cycle progression by c-Jun is p53 dependent.

  1999influential reference
• Defective neural tube morphogenesis and altered apoptosis in the absence of both JNK1 and JNK2.

  1999cited by this paper
• Amino-terminal phosphorylation of c-Jun regulates stress-induced apoptosis and cellular proliferation

  1999influential reference
• Functions of c-Jun in Liver and Heart Development

  1999cited by this paper
• c‐Jun regulates cell cycle progression and apoptosis by distinct mechanisms

  1999cited by this paper
• New insights into tumor suppression: PTEN suppresses tumor formation by restraining the phosphoinositide 3-kinase/AKT pathway.

  1999cited by this paper
• JNK2 is required for efficient T-cell activation and apoptosis but not for normal lymphocyte development.

  1999cited by this paper
• PTEN modulates cell cycle progression and cell survival by regulating phosphatidylinositol 3,4,5,-trisphosphate and Akt/protein kinase B signaling pathway.

  1999cited by this paper
• Adenovirus-mediated wild-type p53 tumor suppressor gene therapy induces apoptosis and suppresses growth of human pancreatic cancer [seecomments].

  1998cited by this paper
• Adenovirus-mediated wild-typep53 tumor suppressor gene therapy induces apoptosis and suppresses growth of human pancreatic cancer

  1998cited by this paper
• PTEN and inherited hamartoma-cancer syndromes

  1998cited by this paper
• Phosphorylation of c-Jun Is Necessary for Apoptosis Induced by Survival Signal Withdrawal in Cerebellar Granule Neurons

  1998cited by this paper
• Induction of apoptosis by the transcription factor c‐Jun

  1997cited by this paper
• PKB/Akt: connecting phosphoinositide 3-kinase to cell survival and beyond.

  1997influential reference
• Absence of excitotoxicity-induced apoptosis in the hippocampus of mice lacking the Jnk3 gene

  1997cited by this paper
• c-fos-induced osteosarcoma formation in transgenic mice: cooperativity with c-jun and the role of endogenous c-fos.

  1995cited by this paper
• A two-motif isoform of the major calcium channel subunit in skeletal muscle.

  1992cited by this paper

• Multi-Target Photoprotection by Taxifolin Against UVB-Induced Keratinocyte Injury Through UVB Filtration, ROS Scavenging and Transcriptomic-Proteomic Reprogramming

  2026cites this paper
• Bisphenol A alters JUN promoter methylation, impairing steroid metabolism in placental cells and linking to sub-representative phenotypes.

  2025cites this paper
• PTEN inhibits scavenger receptor–mediated phagocytosis of methicillin-resistant Staphylococcus aureus

  2025cites this paper
• Endoplasmic Reticulum Stress Modulates Therapeutic Responses in Hepatocellular Carcinoma

  2025cites this paper
• Olive Leaf Extract (OLE) Anti-Tumor Activities Against Hematologic Tumors: Potential Therapeutic Implications for Pediatric Patients with B-Acute Lymphoblastic Leukemia

  2025cites this paper
• Premature cleavage and polyadenylation in the minor intron of PTEN modulate its expression and generates a functional long non-coding RNA in breast cancer

  2024cites this paper
• Hypoxia-Inducible Factor-2α Promotes Liver Fibrosis by Inducing Hepatocellular Death

  2024cites this paper
• Progress in investigating the relationship between Schlafen5 genes and malignant tumors

  2023cites this paper
• An evidence update to explore molecular targets and protective mechanisms of apigenin against abdominal aortic aneurysms based on network pharmacology and experimental validation

  2023cites this paper
• CRISPR-Cas9 based knockout of S100A8 in mammary epithelial cells enhances cell proliferation and triggers oncogenic transformation via the PI3K-Akt pathway: Insights from a deep proteomic analysis.

  2023cites this paper
• Synthetic lethal approaches to target cancers with loss of PTEN function

  2023cites this paper
• RETRACTED ARTICLE: SLFN5 promotes reversible epithelial and mesenchymal transformation in ovarian cancer

  2023cites this paper
• Bistability regulates TNFR2-mediated survival and death of T-regulatory cells

  2023cites this paper
• The regulation of PTEN: Novel insights into functions as cancer biomarkers and therapeutic targets

  2023cites this paper
• FKBP38 Regulates Self-Renewal and Survival of GBM Neurospheres

  2023cites this paper
• PTEN promoter methylation and expression in endometrial cancer tissues.

  2023cites this paper
• Role of Tumor Suppressor PTEN and Its Regulation in Malignant Transformation of Endometrium

  2022cites this paper
• PTEN Dual Lipid- and Protein-Phosphatase Function in Tumor Progression

  2022cites this paper
• Regulatory networks driving expression of genes critical for glioblastoma are controlled by the transcription factor c-Jun and the pre-existing epigenetic modifications

  2022cites this paper
• miR-486-5p and miR-22-3p Enable Megakaryocytic Differentiation of Hematopoietic Stem and Progenitor Cells without Thrombopoietin

  2022cites this paper
• miR-338-3p Blocks TGFβ-Induced Myofibroblast Differentiation through the Induction of PTEN.

  2022cites this paper
• The role of the PTEN/mTOR axis in clinical response of rectal cancer patients

  2022cites this paper
• Notch3 inhibits cell proliferation and tumorigenesis and predicts better prognosis in breast cancer through transactivating PTEN

  2021cites this paper
• Attacking the PI3K/Akt/mTOR signaling pathway for targeted therapeutic treatment in human cancer.

  2021cites this paper
• Regulation of the tumor suppressor PTEN in triple-negative breast cancer.

  2021cites this paper
• The interplay of ROS and the PI3K/Akt pathway in autophagy regulation

  2021cites this paper
• Diethylhexyl phthalate (DEHP) regulates the proliferation and chemosensitivity of esophageal squamous cell carcinoma cells via regulation of PTEN

  2021cites this paper
• NOTCH and EZH2 collaborate to repress PTEN expression in breast cancer

  2021cites this paper
• Human Schlafen 5 Inhibits Proliferation and Promotes Apoptosis in Lung Adenocarcinoma via the PTEN/PI3K/AKT/mTOR Pathway

  2021cites this paper
• CRISPR/Cas9 in epigenetics studies of health and disease.

  2021cites this paper
• Phosphatase and Tensin Homolog in Non-neoplastic Digestive Disease: More Than Just Tumor Suppressor

  2021cites this paper
• Nqo1 ablation inhibits activation of the PI3K/Akt and MAPK/ERK pathways and blocks metabolic adaptation in hepatocellular carcinoma

  2020cites this paper
• Combinatorial effect of miR-486-5p & miR-22-3p mimics thrombopoietin’s impact on hematopoietic stem & progenitor cells

  2020cites this paper
• Essence of PTEN: a Broad-Spectrum Therapeutic Target in Cancer

  2020cites this paper
• FGD1 promotes tumor progression and regulates tumor immune response in osteosarcoma via inhibiting PTEN activity

  2020cites this paper
• ΔNp63α promotes the expression and nuclear translocation of PTEN, leading to cisplatin resistance in oral cancer cells.

  2020cites this paper
• RETRACTED ARTICLE: Stem-like cells of various origins showed therapeutic effect to improve the recovery of spinal cord injury

  2020cites this paper
• Abstract. PTEN inactivation is a frequent event in onco- genesis. Multiple regulatory mechanisms such as promoter hypermethylation, antisense regulation, histone modifications, targeting by microRNAs (miRNAs/miRs) and regulation by transcription factors have all been shown to affect the tumor suppre

  2020cites this paper
• Endoplasmic Reticulum Stress-Mediated p62 Downregulation Inhibits Apoptosis via c-Jun Upregulation

  2020cites this paper
• Role of Ubiquitination in PTEN Cellular Homeostasis and Its Implications in GB Drug Resistance

  2020cites this paper
• Alternate NF-κB-Independent Signaling Reactivation of Latent HIV-1 Provirus

  2019cites this paper
• Signaling Pathways in Leukemic Stem Cells.

  2019cites this paper
• C-Jun drives melanoma progression in PTEN wild type melanoma cells

  2019cites this paper
• PTEN in Lung Cancer: Dealing with the Problem, Building on New Knowledge and Turning the Game Around

  2019cites this paper
• The PTEN Tumor Suppressor Gene in Soft Tissue Sarcoma

  2019cites this paper
• NAD(P)H Quinone Dehydrogenase 1 Ablation Inhibits Activation of the Phosphoinositide 3‐Kinase/Akt Serine/Threonine Kinase and Mitogen‐Activated Protein Kinase/Extracellular Signal‐Regulated Kinase Pathways and Blocks Metabolic Adaptation in Hepatocellular Carcinoma

  2019cites this paper
• PTEN Alterations as a Potential Mechanism for Tumor Cell Escape from PD-1/PD-L1 Inhibition

  2019cites this paper
• ATG7 regulates hepatic Akt phosphorylation through the c‐JUN/PTEN pathway in high fat diet‐induced metabolic disorder

  2019cites this paper
• Rsu1-dependent control of PTEN expression is regulated via ATF2 and cJun

  2019cites this paper
• Repression of Human Papillomavirus Oncogene Expression under Hypoxia Is Mediated by PI3K/mTORC2/AKT Signaling

  2019cites this paper
• Mechanisms of PTEN loss in cancer: It's all about diversity.

  2019cites this paper
• Identification of hub genes in chronically hypoxic myocardium using bioinformatics analysis

  2019cites this paper
• Up-regulation of PTEN via LPS/AP-1/NF-κB pathway inhibits trophoblast invasion contributing to preeclampsia.

  2019cites this paper
• Identification and validation of mRNA 3′untranslated regions of DNMT3B and TET3 as novel competing endogenous RNAs of the tumor suppressor PTEN

  2019cites this paper
• The Mechanisms Underlying PTEN Loss in Human Tumors Suggest Potential Therapeutic Opportunities

  2019cites this paper
• Activating PTEN Tumor Suppressor Expression with the CRISPR/dCas9 System

  2018cites this paper
• Targeting phosphoinositide‐3‐kinase pathway in biliary tract cancers: A remedial route?

  2018cites this paper
• Proprotein convertase subtilisin/kexin type 9 inhibits interferon β expression through interacting with ATF‐2

  2018cites this paper
• PTEN: Tumor Suppressor and Metabolic Regulator

  2018cites this paper
• Regulation and modulation of PTEN activity

  2018cites this paper
• Targeting PTEN in Colorectal Cancers.

  2018cites this paper
• The functions and regulation of the PTEN tumour suppressor: new modes and prospects

  2018cites this paper
• What makes oncogenes mutually exclusive?

  2017cites this paper
• Functional analysis of long non-coding RNAs in cancer

  2017cites this paper
• PTEN: A potential prognostic marker in virus-induced hepatocellular carcinoma

  2017cites this paper
• LncRNA MEG3 downregulation mediated by DNMT3b contributes to nickel malignant transformation of human bronchial epithelial cells via modulating PHLPP1 transcription and HIF-1α translation

  2017cites this paper
• Hepatic MiR-291b-3p Mediated Glucose Metabolism by Directly Targeting p65 to Upregulate PTEN Expression

  2017cites this paper
• AP-1: Its Role in Gastrointestinal Malignancies

  2017cites this paper
• Erratum Erratum to Gene expression profiling of hepatitis Band hepatitis C-related hepatocellular carcinoma using graphical Gaussian modeling

  2017cites this paper
• Regulations of Tumor Suppressor Gene PTEN and Its Potential as Therapeutic Target

  2017cites this paper
• FGFR and PTEN signaling interact during lens development to regulate cell survival.

  2016cites this paper
• The Roles of Unfolded Protein Response Pathways in Chlamydia Pathogenesis

  2016influential citation
• Mechanism of action of ID4 as a tumor suppressor

  2016cites this paper
• Significance of PTEN Phosphorylation and its Nuclear Function in Lung Cancer

  2016cites this paper
• Novel axon projection after stress and degeneration in the Dscam mutant retina.

  2016cites this paper
• UNR/CSDE1 Drives a Post-transcriptional Program to Promote Melanoma Invasion and Metastasis.

  2016cites this paper
• Connexin43 recruits PTEN and Csk to inhibit c-Src activity in glioma cells and astrocytes

  2016cites this paper
• Network modelling reveals the mechanism underlying colitis-associated colon cancer and identifies novel combinatorial anti-cancer targets

  2015cites this paper
• Microenvironment-induced PTEN loss by exosomal microRNA primes brain metastasis outgrowth

  2015cites this paper
• Loss of STAT1 protects hair cells from ototoxicity through modulation of STAT3, c-Jun, Akt, and autophagy factors

  2015cites this paper
• Tumor suppressor NFκB2 p100 interacts with ERK2 and stabilizes PTEN mRNA via inhibition of miR-494

  2015cites this paper
• JNK implication in adipocyte-like cell death induced by chemotherapeutic drug cisplatin.

  2015cites this paper
• EFFECTS OF FYN-RELATED-KINASE ACTIVITY ON BREAST CANCER CELL PROLIFERATION, MIGRATION, INVASION AND COLONY FORMATION

  2015cites this paper
• Focus on PTEN Regulation

  2015cites this paper
• Systematic analysis of BRAFV600E melanomas reveals a role for JNK/c-Jun pathway in adaptive resistance to drug-induced apoptosis

  2015cites this paper
• Selected genes involved in GIST evolution from indolent to advanced tumours

  2015cites this paper
• Investigation of the mechanism of catalysis and regulation of PTEN by C-terminal tail phosphorylation

  2015cites this paper
• The phosphatidylinositol 3-kinase/Akt and c-Jun N-terminal kinase signaling in cancer: Alliance or contradiction? (Review).

  2015cites this paper
• PTEN: Multiple Functions in Human Malignant Tumors

  2015cites this paper
• Selection and Characterization of a DNA Aptamer That Can Discriminate between cJun/cJun and cJun/cFos

  2014cites this paper
• PTEN expression and function in adult cancer stem cells and prospects for therapeutic targeting.

  2014cites this paper
• The multiple layers of non-genetic regulation of PTEN tumour suppressor activity.

  2014cites this paper
• miR-29b suppresses proliferation, migration, and invasion of tongue squamous cell carcinoma through PTEN-AKT signaling pathway by targeting Sp1.

  2014cites this paper
• Therapeutic targeting of cancers with loss of PTEN function.

  2014cites this paper
• The effects of Phosphatase and Tensin Homolog (PTEN) overexpression on longevity of cultured Human Umbilical Vein Endothelial Cells (HUVEC)

  2014cites this paper
• Ectodomain-Specific E-Cadherin Antibody Suppresses Skin SCC Growth and Reduces Tumor Grade: A Multitargeted Therapy Modulating RTKs and the PTEN–p53–MDM2 Axis

  2014cites this paper
• PIASx α enhances SUMO 1 modification of PTEN as a SUMO E 3 ligase

  2013cites this paper
• Mechanisms of Transcriptional Regulation by NFAT and AP-1 Transcriptional Activators

  2013influential citation
• PTEN, Longevity and Age-Related Diseases

  2013cites this paper
• Acetylated Sp1 inhibits PTEN expression through binding to PTEN core promoter and recruitment of HDAC1 and promotes cancer cell migration and invasion.

  2013cites this paper